NMR Precision Metabolomics: Dynamic Peak Sum Thresholding and Navigators for Highly Standardized and Reproducible Metabolite Profiling of Clinical Urine Samples
-
Published:2024-05-10
Issue:5
Volume:14
Page:275
-
ISSN:2218-1989
-
Container-title:Metabolites
-
language:en
-
Short-container-title:Metabolites
Author:
Trimigno Alessia1ORCID, Holderman Nicole R.1, Dong Chen1, Boardman Kari D.1, Zhao Jifang1, O’Day Elizabeth M.1ORCID
Affiliation:
1. Olaris, Inc., Framingham, MA 01702, USA
Abstract
Metabolomics, especially urine-based studies, offers incredible promise for the discovery and development of clinically impactful biomarkers. However, due to the unique challenges of urine, a highly precise and reproducible workflow for NMR-based urine metabolomics is lacking. Using 1D and 2D non-uniform sampled (NUS) 1H-13C NMR spectroscopy, we systematically explored how changes in hydration or specific gravity (SG) and pH can impact biomarker discovery. Further, we examined additional sources of error in metabolomics studies and identified Navigator molecules that could monitor for those biases. Adjustment of SG to 1.002–1.02 coupled with a dynamic sum-based peak thresholding eliminates false positives associated with urine hydration and reduces variation in chemical shift. We identified Navigator molecules that can effectively monitor for inconsistencies in sample processing, SG, protein contamination, and pH. The workflow described provides quality assurance and quality control tools to generate high-quality urine metabolomics data, which is the first step in biomarker discovery.
Reference52 articles.
1. Havelund, J.F., Heegaard, N.H.H., Færgeman, N.J.K., and Gramsbergen, J.B. (2017). Biomarker Research in Parkinson’s Disease Using Metabolite Profiling. Metabolites, 7. 2. Perspective: A Potential Role for NUS in Metabolite-Based In Vitro Diagnostics;Hoyt;Magn. Reson. Chem.,2021 3. Varma, V.R., Oommen, A.M., Varma, S., Casanova, R., An, Y., Andrews, R.M., O’Brien, R., Pletnikova, O., Troncoso, J.C., and Toledo, J. (2018). Brain and Blood Metabolite Signatures of Pathology and Progression in Alzheimer Disease: A Targeted Metabolomics Study. PLoS Med., 15. 4. Bragg, F., Trichia, E., Aguilar-Ramirez, D., Bešević, J., Lewington, S., and Emberson, J. (2022). Predictive Value of Circulating NMR Metabolic Biomarkers for Type 2 Diabetes Risk in the UK Biobank Study. BMC Med., 20. 5. Lipids, Lipoproteins, and Metabolites and Risk of Myocardial Infarction and Stroke;Holmes;J. Am. Coll. Cardiol.,2018
|
|